NuProbe

NuProbe, Inc. was founded in Shanghai in 2016. It is a high-tech enterprise established by world-class scientists based on multiple exclusive technology licenses from Harvard University and Rice University, and invested in by well-known institutions such as Sequoia Capital China Fund. The company possesses several breakthrough molecular diagnostic technologies and has extensive collaborations with multiple renowned academic institutions, medical organizations, and industry enterprises worldwide. NuProbe has subsidiaries in Houston, USA, and Suzhou, China.